JPWO2020219582A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020219582A5 JPWO2020219582A5 JP2021562097A JP2021562097A JPWO2020219582A5 JP WO2020219582 A5 JPWO2020219582 A5 JP WO2020219582A5 JP 2021562097 A JP2021562097 A JP 2021562097A JP 2021562097 A JP2021562097 A JP 2021562097A JP WO2020219582 A5 JPWO2020219582 A5 JP WO2020219582A5
- Authority
- JP
- Japan
- Prior art keywords
- culture medium
- cell culture
- cell
- acid
- aflibercept
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962837263P | 2019-04-23 | 2019-04-23 | |
| US62/837,263 | 2019-04-23 | ||
| PCT/US2020/029370 WO2020219582A1 (en) | 2019-04-23 | 2020-04-22 | Cell culture medium for eukaryotic cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022529485A JP2022529485A (ja) | 2022-06-22 |
| JPWO2020219582A5 true JPWO2020219582A5 (ko) | 2023-04-21 |
Family
ID=70681881
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562097A Pending JP2022529485A (ja) | 2019-04-23 | 2020-04-22 | 真核細胞用の細胞培地 |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US10961500B1 (ko) |
| EP (1) | EP3959234A1 (ko) |
| JP (1) | JP2022529485A (ko) |
| KR (1) | KR20220003563A (ko) |
| CN (1) | CN113710696A (ko) |
| AU (1) | AU2020262117A1 (ko) |
| BR (1) | BR112021020501A2 (ko) |
| CA (1) | CA3136827A1 (ko) |
| EA (1) | EA202192893A1 (ko) |
| IL (1) | IL287387A (ko) |
| MX (1) | MX2021012649A (ko) |
| SG (1) | SG11202111252QA (ko) |
| WO (1) | WO2020219582A1 (ko) |
| ZA (1) | ZA202107808B (ko) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023278525A1 (en) * | 2021-06-29 | 2023-01-05 | Biomarin Pharmaceutical Inc. | Cell culture feed for recombinant adeno-associated virus production in mammalian cells |
| CN118240749B (zh) * | 2024-05-28 | 2024-08-06 | 烟台赛普生物技术有限公司 | 一种灌流培养基及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1312030C (en) * | 1987-11-18 | 1992-12-29 | Brian Maiorella | Method to increase antibody titer |
| JP2000517188A (ja) * | 1996-08-30 | 2000-12-26 | ライフ テクノロジーズ，インコーポレイテッド | 無血清哺乳動物細胞培養培地およびその使用 |
| US7087411B2 (en) * | 1999-06-08 | 2006-08-08 | Regeneron Pharmaceuticals, Inc. | Fusion protein capable of binding VEGF |
| US20030096414A1 (en) * | 2001-03-27 | 2003-05-22 | Invitrogen Corporation | Culture medium for cell growth and transfection |
| DE60309238T2 (de) | 2002-03-08 | 2007-06-06 | Asml Netherlands B.V. | Lithographische Maske, lithographischer Apparat und Verfahren zur Herstellung einer Vorrichtung |
| LT2464725T (lt) | 2009-08-11 | 2020-06-10 | F. Hoffmann-La Roche Ag | Baltymų gamyba ląstelių mitybinėje terpėje, kurioje nėra glutamino |
| EA202090220A3 (ru) * | 2010-07-08 | 2020-08-31 | Баксалта Инкорпорейтид | Способ получения рекомбинантного высокомолекулярного vwf в культуре клеток |
| AR095196A1 (es) * | 2013-03-15 | 2015-09-30 | Regeneron Pharma | Medio de cultivo celular libre de suero |
| TWI797060B (zh) * | 2015-08-04 | 2023-04-01 | 美商再生元醫藥公司 | 補充牛磺酸之細胞培養基及用法 |
-
2020
- 2020-01-27 US US16/752,874 patent/US10961500B1/en active Active
- 2020-04-22 EP EP20725601.7A patent/EP3959234A1/en active Pending
- 2020-04-22 SG SG11202111252QA patent/SG11202111252QA/en unknown
- 2020-04-22 KR KR1020217037669A patent/KR20220003563A/ko unknown
- 2020-04-22 WO PCT/US2020/029370 patent/WO2020219582A1/en unknown
- 2020-04-22 JP JP2021562097A patent/JP2022529485A/ja active Pending
- 2020-04-22 CN CN202080030558.8A patent/CN113710696A/zh active Pending
- 2020-04-22 EA EA202192893A patent/EA202192893A1/ru unknown
- 2020-04-22 MX MX2021012649A patent/MX2021012649A/es unknown
- 2020-04-22 CA CA3136827A patent/CA3136827A1/en active Pending
- 2020-04-22 BR BR112021020501A patent/BR112021020501A2/pt unknown
- 2020-04-22 AU AU2020262117A patent/AU2020262117A1/en active Pending
-
2021
- 2021-03-24 US US17/211,596 patent/US11286460B2/en active Active
- 2021-10-14 ZA ZA2021/07808A patent/ZA202107808B/en unknown
- 2021-10-19 IL IL287387A patent/IL287387A/en unknown
-
2022
- 2022-02-22 US US17/677,163 patent/US11555176B2/en active Active
- 2022-12-13 US US18/080,373 patent/US11821001B2/en active Active
-
2023
- 2023-11-20 US US18/514,880 patent/US20240084248A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7034991B2 (ja) | 改良型細胞培養培地 | |
| KR101828624B1 (ko) | 개선된 세포 배양 방법 | |
| EP2702143B1 (en) | Methods for reducing accumulation of lactate during culturing and method for producing polypeptide | |
| JP6982578B2 (ja) | 細胞培養培地 | |
| JP6177260B2 (ja) | 連続細胞培養で対象となるポリペプチドまたはウイルスを生成する方法 | |
| AU2014288811B2 (en) | Improved process for production of monoclonal antibodies | |
| JP2021107459A (ja) | タンパク質産物の等電性プロファイルをシフトさせる方法およびその使用 | |
| JP2004532642A5 (ko) | ||
| JP2019154450A (ja) | 培養培地の最適化により組換えタンパク質のガラクトシル化を調節する方法 | |
| KR20130098869A (ko) | 개선된 세포 배양 배지 | |
| JP6108170B2 (ja) | 細胞培養用培地 | |
| JPWO2020219582A5 (ko) | ||
| WO2020035050A1 (zh) | 用于调节哺乳动物细胞乳酸代谢的培养基及其应用 | |
| KR101318498B1 (ko) | 재조합 단백질의 생산성 향상을 위한 배양용 배지 첨가용 조성물 | |
| US10526631B1 (en) | Method of reducing serine for asparagine misincorporation | |
| JP2749011B2 (ja) | 無血清培地で増殖継代可能な細胞およびその取得方法 | |
| US20170233695A1 (en) | Cell Culture Media Composition and Methods of Producing Thereof |